Pulling SEC filings + quote and writing the call…

Eastern Bankshares, Inc.
Next earnings Jul 22, 2026 · consensus $0.47 EPS, $312M rev
Last earnings +1.3% on 2026-04-23
Cheap on operating earnings ($1.57 op EPS) but GAAP optics ugly; HarborOne deal + securities losses muddy the FY26 picture.
GAAP Diluted EPS $0.43 · FY2025
Middling fundamentals and a rich price (~85% above fair value) leave little margin of safety — a wait-and-see.
Eastern Bankshares is a 200-year-old eastern-Massachusetts thrift in the middle of a transformation: the HarborOne merger closed November 1, 2025, adding $5.5B in assets and $4.3B in deposits, lifting total assets to $30.6B (+19.7% YoY). The headline numbers look terrible — diluted EPS collapsed 34.8% to $0.43 and net income fell 26.2% to $88.2M — but management explicitly attributes the decline to 'losses on sales of securities during the year ended December 31, 2025 which exceeded losses on sales of securities for the year ended December 31, 2024,' a balance-sheet repositioning rather than core erosion. The MD&A's operating (non-GAAP) net income tells the opposite story: $318.0M vs. $196.6M (+61.8%), with operating basic EPS up 44.2% to $1.57.
Valuation is a tale of two multiples. On GAAP EPS, the stock screens expensively at 49.8x P/E; on the operating EPS figure cited by management ($1.57), the multiple compresses to ~13.6x — a more typical regional-bank valuation. Equity grew 20.2% to $4.34B (largely from the HarborOne share issuance of 26.9M shares), and the balance sheet supports $432M of operating cash flow (+52.3%) plus $213M returned to shareholders via buybacks ($107M, +285%) and dividends ($106M, +28.1%). However, ROE is only 2.0% on GAAP earnings, and liabilities/equity at 6.05x is normal for a bank but leaves the equity exposed to the AOCI swing management flags: 'fair value of our investments... has declined due to increases in interest rates beginning in March 2022 and could decline further' — directly eroding tangible book value per share.
Is EBC a buy? The one-page verdict, explained →
HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $69.4M | $77.3M | $76.9M | $113M | $134M |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $155M | $200M | $232M | $120M | $88.2M |
| Diluted EPS | $0.90 | $1.21 | $1.43 | $0.66 | $0.43 |
| Net margin | 222.8% | 258.4% | 302.1% | 106.2% | 65.8% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Annual meeting vote results filed; routine governance disclosure with no policy shift.
Q1'26 10-Q — first clean quarter of combined EBC+HarborOne balance sheet.
Q1'26 earnings release — first full quarter including HarborOne.
2026 proxy: director slate, say-on-pay, auditor ratification — routine.
FY25 GAAP EPS $0.43 (-35%) on securities losses; op EPS $1.57 (+44%); assets $30.6B.
Q4'25 earnings release covering partial-quarter HarborOne contribution post-close.
Amendment to prior 8-K, likely HarborOne pro forma financials/exhibits.
Q3'25 10-Q — last standalone EBC quarter before HarborOne consolidation.
Amendment to merger-closing 8-K, adding required financial exhibits.
Sources: SEC EDGAR (CIK 0001810546, latest 10-Q filed 2026-05-08) · EODHD · Proprietary analysis · as of 6/25/2026, 12:49:40 PM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 25, 2026, 8:49 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 1 sale
| 2026-06-29 | Borgen Luis Director | Sell | 1.71K @ $21.97 | $37.5K |
| 2026-05-18 | CHUNG JOSEPH Director | Award | 3.88K | |
| 2026-05-18 | Hessan Diane Director | Award | 3.88K | |
| 2026-05-18 | Markell Peter Kenneth Director | Award | 3.88K | |
| 2026-05-18 | Schmidt Cathleen Agnes Director | Award | 3.88K | |
| 2026-05-18 | Holbrook Richard Edward Director | Award | 3.88K | |
| 2026-05-18 | Harlam Bari A Director | Award | 3.88K | |
| 2026-05-18 | Palandjian Leon Aghababai Director | Award | 3.88K |
| Bridgewater Associates | 941K sh | $18.4M |
As of each fund’s latest quarterly 13F — a delayed snapshot, not a live position. All tracked funds →
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1194 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.